Current GMP Guidelines (cGMP)

cGMP refers to the Current Good Manufacturing Practice regulations enforced by the US FDA. cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories.

  • EU-GMP guidelines (European union-GMP guidelines)
  • WHO-GMP guidelines (World health organization-GMP guidelines)
  • GMP for active pharmaceutical products
  • GMP for biopharmaceuticals
  • cGMP quality principles for biologics and biotechnological products
  • Licensing in pharmaceutical production & GMP documentation

Related Conference of Current GMP Guidelines (cGMP)

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Current GMP Guidelines (cGMP) Conference Speakers

Recommended Sessions

Related Journals

Are you interested in